← Back to Search

Whole body vibration training for Neurologic Locomotion Disorder (CP_WBVT Trial)

N/A
Waitlist Available
Led By Jeffrey D Eggleston, PhD
Research Sponsored by University of Texas, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

CP_WBVT Trial Summary

This study is evaluating whether a four-week whole-body vibration training intervention can improve gait function in children with Cerebral Palsy.

Eligible Conditions
  • Neurologic Locomotion Disorder
  • Neurologic Gait Disorders
  • Cerebral Palsy

CP_WBVT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Timed up and go test
Two-minute walk test
Secondary outcome measures
Lower extremity gait function

CP_WBVT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Vibration groupExperimental Treatment1 Intervention
This group will receive vibration stimulation while standing on a side-alternating vibration platform. Vibration sessions will occur three times per week over four-weeks. Each session will include three-minutes of vibration followed by three-minutes rest, completing this sequence three times per session
Group II: Control groupActive Control1 Intervention
This group will not receive vibration, but will rather hear a recording of the vibration, while still standing on the vibration platform. Still, this group will receive this training three times per week over four-weeks with a similar three-minute rotation as the vibration group.

Find a Location

Who is running the clinical trial?

University of Texas, El PasoLead Sponsor
13 Previous Clinical Trials
2,683 Total Patients Enrolled
Jeffrey D Eggleston, PhDPrincipal InvestigatorThe University of Texas at El Paso

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025